← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Fluent Biosciences Inc.
Watertown, MA
$5,742,910
Total funding
5
Grants
Funding over time
peak $1.9M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,742,910 · 5
By mechanism
R44$5,055,486 · 3
R43$687,424 · 2
Investigators at Fluent Biosciences Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Commercialization of methods and reagents for high-throughput single cell analysis$1,146,224
R44 · FY2023 · GM
Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq$1,105,490
R44 · FY2020 · CA
New tools for highly accessible single cell RNA sequencing$903,654
R44 · FY2022 · GM
Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq$825,632
R44 · FY2021 · CA
New tools for highly accessible single cell RNA sequencing$775,245
R44 · FY2023 · GM
PIPsceq: powering single cell RNA sequencing into the million cell era$399,059
R43 · FY2020 · GM
Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq$299,241
R44 · FY2019 · CA
Anti-cancer drug screening enabled by Pre-templated Instant Partitions and single cell RNA sequencing$288,365
R43 · FY2019 · CA